UTERINE LEIOMYOMAS IN THE INFERTILE PATIENT - PREOPERATIVE LOCALIZATION WITH MR IMAGING VERSUS US AND HYSTEROSALPINGOGRAPHY

UTERINE LEIOMYOMAS IN THE INFERTILE PATIENT - PREOPERATIVE LOCALIZATION WITH MR IMAGING VERSUS US AND HYSTEROSALPINGOGRAPHY
复制标题

DOI:
10.1148/radiology.167.3.3283833
复制
发表时间:
1988-06-01
期刊:
影响因子:
19.7
通讯作者:
NORUSIS, M
NORUSIS, M
中科院分区:
医学1区
文献类型:
--
作者:
DUDIAK, CM;TURNER, DA;NORUSIS, M

文献摘要

被引文献

相似文献

11名有不孕症和子宫肌瘤病史的妇女在肌瘤切除术前接受了盆腔磁共振(MR)成像。9例患者还接受了术前盆腔超声检查(US),10例患者接受了子宫输卵管造影。所有研究均由独立观察员进行前瞻性解释。每种成像方式,位置(11个解剖段之一),大小和检测子宫肌瘤的外观进行了确定,并与手术和组织学结果进行了比较。在9名同时接受MR和US检查的患者中,MR成像对异常节段的敏感性(85%)和准确性(94%)明显优于US(敏感性= 69%,P = 0.015;准确性= 87%,P = 0.043)。10例同时行MR和子宫输卵管造影的患者中,MR成像的敏感性(91%)和准确性(96%)优于子宫输卵管造影(敏感性= 18%,P = 0.0005;准确性= 72%,P = 0.0005)。三种方法的特异性无显著差异(MR、US和子宫输卵管造影分别为100%、97%和98%)。这些数据表明,磁共振成像是上级优于超声或子宫输卵管造影术术前定位子宫肌瘤。
Eleven women with a history of infertility and uterine leiomyomas underwent magnetic resonance (MR) imaging of the pelvis prior to myomectomy. Nine also underwent preoperative pelvic ultrasonography (US), and ten underwent hysterosalpingography. All studies were interpreted prospectively by independent observers. With each imaging modality, the location (one of 11 anatomic segments), size, and appearance of detected uterine leiomyomas were determined and compared with surgical and histologic findings. Among the nine patients who underwent both MR and US, the sensitivity (85%) and accuracy (94%) of MR imaging for abnormal segments was significantly better than that of US (sensitivity = 69%, P = .015; accuracy = 87%, P = .043). For the ten patients who underwent both MR and hysterosalpingography, the sensitivity (91%) and accuracy (96%) of MR imaging was better than that of hysterosalpingography (sensitivity = 18%, P = .0005; accuracy = 72%, P = .0005). The specificities of the three modalities did not significantly differ (100%, 97% and 98% for MR, US, and hysterosalpingography, respectively). These data suggest that MR imaging is superior to US or hysterosalpingography for preoperatively locating uterine leiomyomas.